Sign in to view content

Additional Visual and Anatomic Outcomes of Intravitreal Aflibercept Injection, 8 mg vs 2 mg: Post Hoc Analysis of the Phase 2 CANDELA Study

Priya Sharma Vakharia, MD

Video
Published 2023

Related

Ranibizumab Induces Regression of Diabetic Retinopathy
Charles C Wykoff, MD, PhD, FASRS
Updates from the Field
2016
Canadian Treat-and-Extend Analysis Trial with Ranibizumab in Patients With Neovascular AMD: CANTREAT Study 1-Year Results
Peter J. Kertes, MD, FRCS(C)
Updates from the Field
2018
Widefield Fluorescein Angiographic-Guided Aflibercept (WFFAGA) Monotherapy for Proliferative Diabetic Retinopathy (PDR)
Dennis M. Marcus, MD
Annual Meeting Talks
2019

Category: AMD-Neovascular

See more